RJFSA
IBIO icon

Raymond James Financial Services Advisors’s iBio IBIO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23
Closed -$12K – 3228
2020
Q4 		$12K Buy
+23
New +$18.7K ﹤0.01% 2967

Other funds holding IBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Raymond James Financial Services Advisors's IBIO Position: Q1 2021 in Review

Raymond James Financial Services Advisors sold out of iBio (IBIO) in Q1 2021, closing a stake of 23 shares — an estimated $12K sold.

Raymond James Financial Services Advisors first reported a position in IBIO in Q4 2020 and held it in 1 quarter. The position peaked at $12K in Q4 2020. 91 funds tracked by Wall St. Rank hold IBIO as of Q1 2021.

  • Raymond James Financial Services Advisors reported no remaining iBio position as of Q1 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 23 iBio shares in Q1 2021, an estimated $12K.
  • Raymond James Financial Services Advisors first reported a position in iBio in Q4 2020 and held it in 1 quarter.
  • Raymond James Financial Services Advisors's iBio position peaked at $12K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held iBio as of Q1 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2021, filed 14 May 2021.